دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Transforming Mental Health Care Delivery Through Implementation Science and Behavioral Economics
Rinad S. Beidas, PhD1,2; Alison M. Buttenheim, PhD, MBA3; David S. Mandell, ScD1
doi : 10.1001/jamapsychiatry.2021.1120
JAMA Psychiatry. 2021;78(9):941-942
Ten Practical Recommendations for Improving Blinding Integrity and Reporting in Psychotherapy Trials
David Mataix-Cols, PhD1,2; Erik Andersson, PhD3
doi : 10.1001/jamapsychiatry.2021.1419
JAMA Psychiatry. 2021;78(9):943-944
Implications of Global and Local Inequalities in COVID-19 Vaccine Distribution for People With Severe Mental Disorders in Latin America
Franco Mascayano, MPH1,2; Andrea Bruni, MD3; Ezra Susser, MD, DrPH1,2
doi : 10.1001/jamapsychiatry.2021.1416
JAMA Psychiatry. 2021;78(9):945-946
Insights on Neural Response to Racist Threats
Robert O. Motley Jr, PhD1; Cynthia Rogers, MD2
doi : 10.1001/jamapsychiatry.2021.1254
JAMA Psychiatry. 2021;78(9):947-948
Changes in Attributable Fractions and Causal Inference for Schizophrenia and Other Psychiatric Outcomes
Tyler J. VanderWeele, PhD1
doi : 10.1001/jamapsychiatry.2021.1256
JAMA Psychiatry. 2021;78(9):949-950
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial
Kristina M. Deligiannidis, MD1,2; Samantha Meltzer-Brody, MD, MPH3; Handan Gunduz-Bruce, MD, MBA4; James Doherty, PhD4; Jeffrey Jonas, MD4; Sigui Li, MS4; Abdul J. Sankoh, PhD4; Christopher Silber, MD4; Andrew D. Campbell, PhD4; Brian Werneburg, PhD4; Stephen J. Kanes, MD, PhD4; Robert Lasser, MD, MBA4
doi : 10.1001/jamapsychiatry.2021.1559
JAMA Psychiatry. 2021;78(9):951-959
Postpartum depression (PPD) is one of the most common medical complications during and after pregnancy, negatively affecting both mother and child.
Effect of Matching Therapists to Patients vs Assignment as Usual on Adult Psychotherapy Outcomes: A Randomized Clinical Trial
Michael J. Constantino, PhD1; James F. Boswell, PhD2; Alice E. Coyne, MS1; Thomas P. Swales, PhD3; David R. Kraus, PhD4
doi : 10.1001/jamapsychiatry.2021.1221
JAMA Psychiatry. 2021;78(9):960-969
Psychotherapists possess strengths and weaknesses in treating different mental health problems, yet performance information is rarely harnessed in mental health care (MHC). To our knowledge, no prior studies have tested the causal efficacy of prospectively matching patients to therapists with empirically derived strengths in treating patients’ specific concerns.
Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis
Gonzalo Salazar de Pablo, MD1,10,11; Joaquim Radua, MD, PhD1,2,3; Joana Pereira, MD4; Ilaria Bonoldi, MD, PhD5; Vincenzo Arienti, MD6; Filippo Besana, MD6; Livia Soardo, MD6; Anna Cabras, MD7; Lydia Fortea, MSc2,8; Ana Catalan, MD, PhD1,9; Julio Vaquerizo-Serrano, MD5,10,11; Francesco Coronelli, MD6; Simi Kaur, MSc1; Josette Da Silva, MSc1; Jae Il Shin, MD, PhD12; Marco Solmi, MD, PhD1,13; Natascia Brondino, MD, PhD6; Pierluigi Politi, MD, PhD6; Philip McGuire, MB ChB, MD, PhD5,14; Paolo Fusar-Poli, MD, PhD1,6,14
doi : 10.1001/jamapsychiatry.2021.0830
JAMA Psychiatry. 2021;78(9):970-978
Estimating the current likelihood of transitioning from a clinical high risk for psychosis (CHR-P) to psychosis holds paramount importance for preventive care and applied research.
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis
Thomas Santo Jr, MPH1; Brodie Clark, BPsych1; Matt Hickman, PhD2; Jason Grebely, PhD3; Gabrielle Campbell, PhD1,4; Luis Sordo, MD, PhD5,6; Aileen Chen, BPsych1,7; Lucy Thi Tran, BPsychSc1; Chrianna Bharat, BSc1; Prianka Padmanathan, MRCPsych2; Grainne Cousins, PhD8; Julie Dupouy, MD, PhD9,10; Erin Kelty, PhD11; Roberto Muga, MD, PhD12; Bohdan Nosyk, PhD13,14; Jeong Min, MSc13; Raimondo Pavarin, MPH15,16; Michael Farrell, MD1; Louisa Degenhardt, PhD1
doi : 10.1001/jamapsychiatry.2021.0976
JAMA Psychiatry. 2021;78(9):979-993
Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the relationship between OAT and specific causes of mortality.
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial
Sidhant Chopra, BSc1,2; Shona M. Francey, PhD3,4; Brian O’Donoghue, MD, PhD3,4; Kristina Sabaroedin, BSc1,2; Aurina Arnatkeviciute, PhD1; Vanessa Cropley, PhD5; Barnaby Nelson, PhD3,4; Jessica Graham, MClinPsych3,4; Lara Baldwin, BSc3,4; Steven Tahtalian, BSc5; Hok Pan Yuen, PhD3,4; Kelly Allott, DPsych3,4; Mario Alvarez-Jimenez, PhD3,4; Susy Harrigan, PhD6,7; Christos Pantelis, MD, PhD5; Stephen J. Wood, PhD3,4,8; Patrick McGorry, MD, PhD3,4; Alex Fornito, PhD1,2
doi : 10.1001/jamapsychiatry.2021.1422
JAMA Psychiatry. 2021;78(9):994-1004
Altered functional connectivity (FC) is a common finding in resting-state functional magnetic resonance imaging (rs-fMRI) studies of people with psychosis, yet how FC disturbances evolve in the early stages of illness, and how antipsychotic treatment influences these disturbances, remains unknown.
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma
Negar Fani, PhD1; Sierra E. Carter, PhD2; Nathaniel G. Harnett, PhD3,4; Kerry J. Ressler, MD, PhD1,3,4; Bekh Bradley, PhD1,5
doi : 10.1001/jamapsychiatry.2021.1480
JAMA Psychiatry. 2021;78(9):1005-1012
Racial discrimination has a clear impact on health-related outcomes, but little is known about how discriminatory experiences are associated with neural response patterns to emotionally salient cues, which likely mediates these outcomes.
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark
Carsten Hjorthøj, PhD1,2,3; Christine Merrild Posselt, MSc1; Merete Nordentoft, DrMedSc1,3
doi : 10.1001/jamapsychiatry.2021.1471
JAMA Psychiatry. 2021;78(9):1013-1019
Cannabis use and potency of cannabis have increased during the past 2 decades. If the association between cannabis use and schizophrenia is causal, this should be reflected in an increase in the proportion of cases of schizophrenia being attributable to cannabis, the population-attributable risk fraction (PARF).
Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness
Weiqiu Cheng, PhD1; Oleksandr Frei, PhD1; Dennis van der Meer, PhD1,2; Yunpeng Wang, PhD3; Kevin S. O’Connell, PhD1; Yunhan Chu, PhD1; Shahram Bahrami, PhD1; Alexey A. Shadrin, PhD1; Dag Alnæs, PhD1; Guy F. L. Hindley, MBBS, MRes1,4; Aihua Lin, PhD1; Naz Karadag, MSc1; Chun-Chieh Fan, PhD5,6; Lars T. Westlye, PhD1,7; Tobias Kaufmann, PhD1,8; Espen Molden, PhD9,10; Anders M. Dale, PhD11,12,13; Srdjan Djurovic, PhD14,15; Olav B. Smeland, MD, PhD1; Ole A. Andreassen, MD, PhD1
doi : 10.1001/jamapsychiatry.2021.1435
JAMA Psychiatry. 2021;78(9):1020-1030
Schizophrenia is a complex heritable disorder associated with many genetic variants, each with a small effect. While cortical differences between patients with schizophrenia and healthy controls are consistently reported, the underlying molecular mechanisms remain elusive.
Association of Cannabis Use During Adolescence With Neurodevelopment
Matthew D. Albaugh, PhD1; Jonatan Ottino-Gonzalez, PhD1; Amanda Sidwell, BS1; Claude Lepage, PhD2; Anthony Juliano, PsyD1; Max M. Owens, PhD1; Bader Chaarani, PhD1; Philip Spechler, PhD1; Nicholas Fontaine, BS1; Pierre Rioux, MSc2; Lindsay Lewis, PhD2; Seun Jeon, PhD2; Alan Evans, PhD2; Deepak D’Souza, MD3; Rajiv Radhakrishnan, MD3; Tobias Banaschewski, MD, PhD4; Arun L. W. Bokde, PhD5; Erin Burke Quinlan, PhD6; Patricia Conrod, PhD7; Sylvane Desrivières, PhD6; Herta Flor, PhD8,9; Antoine Grigis, PhD10; Penny Gowland, PhD11; Andreas Heinz, MD, PhD12,13,14; Bernd Ittermann, PhD15; Jean-Luc Martinot, MD, PhD16; Marie-Laure Paillère Martinot, MD, PhD17,18,19; Frauke Nees, PhD4,8,20; Dimitri Papadopoulos Orfanos, PhD10; Tomáš Paus, MD, PhD21,22,23; Luise Poustka, MD24; Sabina Millenet, PhD4; Juliane H. Fröhner, MSc25; Michael N. Smolka, MD25; Henrik Walter, MD, PhD12,13,14; Robert Whelan, PhD26; Gunter Schumann, MD6,27,28,29,30; Alexandra Potter, PhD1; Hugh Garavan, PhD1; for the IMAGEN Consortium
doi : 10.1001/jamapsychiatry.2021.1258
JAMA Psychiatry. 2021;78(9):1031-1040
Animal studies have shown that the adolescent brain is sensitive to disruptions in endocannabinoid signaling, resulting in altered neurodevelopment and lasting behavioral effects. However, few studies have investigated ties between cannabis use and adolescent brain development in humans.
Suicide Attempts of Muslims Compared With Other Religious Groups in the US
Rania Awaad, MD1; Osama El-Gabalawy, MD, MS2; Ebony Jackson-Shaheed, MPH3,4; Belal Zia, MA5; Hooman Keshavarzi, PsyD6; Dalia Mogahed, MBA7; Hamada Altalib, DO, MPH4,8
doi : 10.1001/jamapsychiatry.2021.1813
JAMA Psychiatry. 2021;78(9):1041-1044
